Back to Rankings

HURA

TuHURA BiosciencesA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
HURA vs peer average
91/100
HURA vs. peer average (A vs. D)
Grade spread
A 1 · B 2 · C 2 · D 2 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ACAD is the first available peer comparator.

Small/medium-cap biotech with rare-disease programs and similar liquidity profile; useful operational comparison.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerACADACADIA
HURA
TuHURA Biosciences
ACAD
ACADIA
Grade
A
C
Momentum
98
27
Value
42
62
Sentiment
52
75
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs ACAD

HURA / ACAD
Grade Position
Above peers
HURA vs. peer average (A vs. D)
91/100
Momentum
98
HURA
Value
42
ACAD
Sentiment
52
ACAD

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HURA
1
ACAD
ACAD
C
60/100
+2
2
CRSP
CRSP
B
80/100
+1
3
EDIT
EDIT
B
80/100
+1
4
CRBP
Corbus Pharmaceuticals Holdings Inc Common
D
40/100
+3
5
AGEN
Agenus Inc Common
F
20/100
+4
ACAD is the first peer returned for this comparison set.